shutterstock
Solcara Health Blog

Is NAD+ IV Therapy Worth It? An Honest Look at the Evidence for Charleston Patients

Popular, plausible, and poorly proven. A Charleston PA-C walks through what the human studies on NAD+ IV actually show, without the hype.

A smiling woman relaxing with a book in a cream lounge chair in a sunlit room full of palms.
Promising biology is not the same as a proven therapy. The difference is the evidence.
Here is the honest answer most Charleston clinics will not give you: NAD+ IV therapy is popular and biologically plausible, but it is not proven to improve energy, aging, or any health outcome in humans, and it is not FDA-approved. The strongest human evidence is for raising a blood marker, not for making you healthier, and that evidence is actually stronger for oral precursors than for the IV drip.[4][5] If you still want to try it, that can be a reasonable personal choice, but it should be an informed one.

This page is the evidence review the vendor pages skip. We will cover what NAD+ actually is, what the human studies really show (including the ones that undercut the marketing), how IV compares with oral precursors, what it costs and risks, and an honest way to decide whether it is worth it for you. The goal is not to sell you a drip or talk you out of one. It is to tell you the truth so you can choose.

Key takeaways
  • There is no adequately powered randomized trial showing IV NAD+ improves energy, aging markers, or any clinical outcome in people. The human IV data is limited to small pilot studies.[3][4]
  • The best-known IV study infused NAD+ into 11 healthy adults over 6 hours; blood NAD+ did not even rise for the first 2 hours, and much of it was excreted in urine.[3]
  • Oral NAD+ precursors have better human evidence. A placebo-controlled trial found oral nicotinamide riboside raised blood NAD+ by about 60 percent, without an IV.[5]
  • A head-to-head human study found IV nicotinamide riboside raised NAD+ faster than IV NAD+, which needed a far longer infusion and was less well tolerated. It was an industry-funded preprint, so read it with that in mind.[6]
  • IV NAD+ is compounded and not FDA-approved for wellness use. There is no FDA-approved NAD+ injection.[7]
  • Raising a blood NAD+ level is not the same as a proven health benefit, for any route. Claims about reversing aging, curing fatigue, or treating addiction run well ahead of the evidence.
Section 01 / The biology

What NAD+ is, and why it is hyped

NAD+ (nicotinamide adenine dinucleotide) is a real and important molecule. It is a coenzyme your cells use in energy metabolism and as a substrate for repair enzymes, and laboratory and animal work has made it one of the most interesting molecules in aging research.[1] That part is legitimate science, which is exactly why the marketing around it is so effective: it starts from a true premise and then sprints past the evidence.

The usual pitch is that NAD+ declines with age, so topping it up with an IV will restore youthful energy. The decline is real in some tissues, but even that is more nuanced than the ads suggest. A 2022 review concluded that the human evidence for a universal, body-wide NAD+ decline is limited and often based on a single tissue such as skeletal muscle.[2] So the premise is partly true and partly overstated, and the leap from that premise to the drip is where the science runs out.

The honest framing is simple. NAD+ matters, its biology is promising, and it is reasonable that researchers are excited. None of that proves that infusing it into your arm does anything you can feel or measure. Those are different claims, and a careful clinic keeps them separate.

Oral precursors (NR / NMN)

Have human randomized trials showing they raise blood NAD+ (about 60% with NR), taken as a daily capsule. More human evidence than the IV, though a health benefit is still unproven.

IV NAD+ infusion

Compounded and not FDA-approved. Human data is a few small pilots measuring blood levels, not benefit, and much of an infusion is excreted in urine. A 2 to 6 hour drip.

Section 02 / The human evidence

What the human evidence actually shows

This is the part that matters, so here it is plainly. No adequately powered randomized controlled trial has shown that IV NAD+ improves energy, aging markers, longevity, or any health outcome in humans. The entire human IV NAD+ literature is a handful of small pilot studies, and they measure what happens to blood and urine, not whether you get healthier.[4]

The best-known one is telling. In a 2019 study, researchers infused 750 mg of NAD+ into 11 healthy adults over 6 hours and tracked their blood and urine. Blood NAD+ did not rise at all for the first 2 hours, because the body took it up and broke it down rapidly, and the researchers measured increased NAD+ and its metabolites being excreted in urine.[3] In other words, a slow, expensive, six-hour infusion, and a large share of it leaves in your urine. That is not a knock on the researchers, who did careful work. It is a reality check on the marketing.

A 2023 systematic review tried to pool the evidence across NAD therapies and found only 10 studies totaling 489 participants, most using oral forms, across a scatter of conditions, and concluded the evidence was preliminary and that more trials were needed.[4] When the entire global evidence base for a therapy is a few hundred people across mixed conditions, confident claims about what it will do for you are not coming from the data.

Considering NAD+ in Charleston? We will give you the honest version first, including whether oral precursors make more sense for you. See how we approach it on the NAD therapy page, or call 843-981-0870 to talk it through before you book.
Section 03 / IV vs oral

IV NAD+ vs oral precursors

Here is the twist the drip clinics rarely mention: the better human evidence is for the pills, not the IV. Oral NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have been tested in randomized, placebo-controlled human trials, and they do reliably raise blood NAD+. In one double-blind trial, oral NR at 1,000 mg a day raised the blood NAD+ level by about 60 percent compared with placebo, and it was well tolerated, no needle required.[5] That is more and better human data than exists for IV NAD+ doing anything.

A head-to-head study made the comparison directly. It tested IV nicotinamide riboside against IV NAD+ in healthy adults and found that the NR raised blood NAD+ more and faster, while the NAD+ infusion needed a much longer run time and was less well tolerated.[6] One important caveat: that study was a preprint, not yet peer-reviewed, and it was funded by a company that sells nicotinamide riboside, so it has a built-in interest in the result. Even accounting for that bias, it does not support the idea that the NAD+ drip is the superior, most direct route.

The common sales line is that IV delivers NAD+ straight to your cells while pills get destroyed in digestion. The human data does not support that. Infused NAD+ appears to be broken down in the bloodstream before it ever reaches your cells intact, which is likely why so much shows up in urine.[3] No human study shows IV NAD+ raising the NAD+ inside your cells better than oral precursors do. If anyone tells you otherwise, ask them for the trial.

Section 04 / Weighing it

Is NAD+ IV worth it? Weighing it honestly

So is it worth it? That depends on what you expect and what you value, because the evidence cannot promise you a benefit. The table below lays out the three common routes honestly, so you can see what you are actually buying with each.

What human trials have actually shown. The evidence gap, by what was tested in people. Oral NR raised blood NAD+ (randomized trial)~60% rise IV NAD+ improving a health outcome0 trials to date Raising a blood NAD+ level is not the same as a proven benefit, for any route. Sources: Martens 2018 (oral NR); IV NAD+ outcome literature.
More human evidence exists for the pills than for the drip, and neither proves a health benefit yet.
RouteHuman evidenceHow it is takenHonest bottom line
IV NAD+Small pilots only; no outcome trials2 to 6 hour infusion in clinicUnproven for benefit, not FDA-approved, expensive
Oral NR or NMNRCTs show it raises blood NAD+Daily capsule at homeBetter evidence it raises NAD+; benefit still unproven
Doing nothing yetThe honest defaultNothingReasonable while the evidence matures
Which location fits you?

Six things to weigh

Tick the ones that are true for you. The more you can tick, the more informed the choice.

The fair way to read that table is this. If your goal is a proven health benefit, no route delivers one yet, and the honest default of waiting is not a bad choice. If you simply want to raise your blood NAD+ and are curious, oral precursors have more evidence and far less hassle. And if you specifically want the IV experience and understand it is unproven, that can still be a reasonable personal choice, as long as nobody is promising you results the science cannot back. What you should not do is pay for a drip because someone told you it reverses aging. It has not been shown to.

Section 05 / Safety and cost

Safety, side effects, and cost

IV NAD+ is generally considered safe when infused slowly by trained staff, but it is not side-effect free. Infused too fast, it commonly causes flushing, nausea, abdominal or muscle cramping, chest tightness, and lightheadedness, which is exactly why reputable clinics run it slowly over hours rather than minutes.[3] The slow drip that minimizes those effects is also what makes it a multi-hour commitment.

On regulation, be clear-eyed: there is no FDA-approved NAD+ injection. The NAD+ used in IV therapy is compounded, meaning it is mixed by a pharmacy and falls outside the FDA approval and manufacturing-oversight process that applies to approved drugs.[7] That does not make it inherently unsafe, but it does mean the usual guarantees of review are not there, so the quality of the clinic and its pharmacy matters a great deal.

Cost is the other half of worth it. IV NAD+ is among the more expensive wellness services, usually sold as single infusions or packages, and because the benefit is unproven, you are paying for a possibility, not a result. We keep the specifics current on our guide to NAD therapy cost in Charleston so you can see what you would actually spend before you decide. A therapy that might do nothing is not automatically a bad buy, but it should be priced into your expectations honestly.

Section 06 / Deciding honestly

Deciding about NAD+ in Charleston

Plenty of places in Charleston will book you an NAD+ drip today and tell you it will change your life. We take a different approach at Solcara: we offer NAD therapy, and we will tell you the truth about it first. For most people, the honest conversation covers your actual goals, whether oral precursors make more sense for you, what the infusion can and cannot be expected to do, and whether the cost fits a benefit that is still unproven. If you are chasing low energy or fatigue, that same visit is a chance to run real advanced testing and find a cause we can actually treat, rather than infusing a molecule and hoping.

NAD+ is a fascinating area of medicine, and it may well earn its reputation as the science matures. Today, the honest verdict is that it is popular, plausible, poorly proven in humans, and not FDA-approved. If that is a tradeoff you want to make with open eyes, we will do it carefully and well. If you would rather spend your money where the evidence is stronger, we will tell you that too. Call 843-981-0870 and we will give it to you straight.

NAD Therapy at Solcara

What we offer and how we talk about the evidence. Read NAD Therapy at Solcara.

Advanced Testing in Charleston

Finding a real, treatable cause of low energy. Read Advanced Testing in Charleston.

Longevity Medicine in Downtown Charleston

Evidence-based longevity care, not hype. Read Longevity Medicine in Downtown Charleston.

Ask Ashley
Ashley Harwyn, PA-C Ashley Harwyn, PA-C PA-C, ABAAHP · Founder, Solcara Health Online

Tap a question to ask

Get the honest version first

NAD therapy in Mount Pleasant or at The Longevity Club downtown, with an honest read on the evidence and whether it is worth it for you, before you book a thing.

BOOK A CONSULTATION →

Or call 843-981-0870

About the author
Ashley Harwyn, PA-C, founder of Solcara Health in Charleston, South Carolina.

Ashley Harwyn, PA-C, ABAAHP

Founder, Solcara Health · Diplomate, American Board of Anti-Aging Health Practitioners (ABAAHP)

Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats women as whole people and tells them the truth about what the evidence does and does not support.

Full bio →

References

Peer-reviewed human studies and reviews of NAD+ metabolism, the IV NAD+ pilot and systematic-review literature, the oral precursor trials, and FDA compounding guidance, each accessed October 1, 2026.

  1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021. nature.com
  2. Peluso A, Damgaard MV, Mori MAS, Treebak JT. Age-Dependent Decline of NAD+ - Universal Truth or Confounded Consensus?. Nutrients. 2022. pmc.ncbi.nlm.nih.gov
  3. Grant R, Berg J, Mestayer R, et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. 2019. pmc.ncbi.nlm.nih.gov
  4. Radenkovic D, Reason, Verdin E. Evaluation of Safety and Effectiveness of NAD in Different Clinical Conditions: A Systematic Review. American Journal of Physiology-Endocrinology and Metabolism. 2023. pubmed.ncbi.nlm.nih.gov
  5. Martens CR, Denman BA, Mazzo MR, et al. Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults. Nature Communications. 2018. nature.com
  6. Freeberg KA, Udovich CC, Martens CR, et al. Randomized, Placebo-Controlled, Pilot Clinical Study Evaluating Acute IV Nicotinamide Riboside and NAD+ in Healthy Adults (preprint, industry-funded). medRxiv. 2024. medrxiv.org
  7. U.S. Food and Drug Administration. Human Drug Compounding: compounded drugs are not FDA-approved. 2026. fda.gov

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. It describes a regulatory labeling change and general treatment categories; it is not a recommendation that any individual start, stop, or change a medication. Hormone therapy of any kind, including local vaginal estrogen, requires evaluation by a qualified, licensed clinician who knows your personal and family history. Consult a qualified healthcare provider before making medical decisions. Information reflects sources available as of October 1, 2026.

Ashley Harwyn, PA-C, ABAAHP, is a Diplomate of the American Board of Anti-Aging Health Practitioners (ABAAHP) through A4M and the founder of Solcara Health. Solcara serves South Carolina from Downtown Charleston (163 Rutledge Ave, Ste 202, The Longevity Club) and Mt. Pleasant (496 Bramson Ct, Ste 120).

Return to blog